HIROMI MAHON: Open Payments
NPI 1457668147 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,139 in 67 payments from 17 companies in 2025. Trend: 2023 $957 · 2024 $922 · 2025 $1,139
Food & beverage: $1,139
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 15 | $270 |
| ABBVIE INC. | 18 | $263 |
| Phathom Pharmaceuticals, Inc. | 5 | $74 |
| Novo Nordisk Inc | 3 | $72 |
| GlaxoSmithKline, LLC. | 4 | $66 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| Exact Sciences Corporation | 3 | $58 |
| Abbott Laboratories | 3 | $55 |
| Amgen Inc. | 3 | $47 |
| Aimmune Therapeutics, Inc. | 2 | $34 |
Products named: MOUNJARO, UBRELVY, QULIPTA, VOQUEZNA, Wegovy, ZEPBOUND, The Cologuard Plus Collection Kit, FREESTYLE LIBRE 3.
Industry payments across NY — which companies pay providers there.
